ICU Medical (NSDQ:ICUI) posted fourth-quarter results today that beat the revenue consensus on Wall Street but missed on earnings.
The San Clemente, Calif.-based company reported profits of $20.6 million, or 96¢ per share, on sales of $315.5 million for the three months ended Dec. 31, 2019, for a bottom-line sales loss of -7.3% compared with Q4 2018.
Diluted earnings per share were 96¢, 37¢ behind The Street, where analysts were looking for sales of $302.9 million.
“Fourth-quarter revenue and adjusted EBITDA were generally in line with our expectations,” CEO Vivek Jain said in a news release.
The company said it expects to log adjusted EBITDA in the range of $240 million to $260 million with an adjusted diluted EPS range of $6.50 to $7.20.
Shares in ICUI were down -2.52% to $195.30 apiece at market open.
